Endpoints News
Endpoints News is an independent biotech and pharma news organization providing breaking news, analysis, and exclusive coverage of the science, money, and power driving the biopharma industry, now part of the Financial Times family.
Company facts
- Founded
- 2016
- Headquarters
- United States
- CEO
- Arsalan Arif, John Carroll
About
Endpoints News is an independent news organization that has established itself as the biopharma world's leading source for breaking news, smart analysis, and exclusive access. Founded in 2016, the company has grown to become an essential daily read for industry leaders globally, covering the critical intersection of science, money, and power that drives the biotechnology and pharmaceutical sectors. The publication delivers comprehensive reporting on the science, people, and financial forces shaping the industry, with a readership exceeding 290,000 registered professionals. Now part of the Financial Times family, Endpoints News continues to expand its reach through breaking news coverage, in-depth analysis, live and virtual events, and award-winning journalism. The organization maintains a robust digital presence across multiple platforms and topic channels, including AI drug discovery, FDA policy, biotech financing, M&A dealmaking, cell and gene therapy, and drug pricing. Endpoints also produces signature industry events and the Endpoints 11 awards program, which recognizes the most promising startups in biopharma. The company's newsroom and business operations are headquartered in Lawrence, Kansas, with coverage spanning global biotech markets including Asia and Europe.